Literature DB >> 33850223

Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population.

Jun-Yi Luo1,2, Bin-Bin Fang1,2, Guo-Li Du3, Fen Liu1,2, Yan-Hong Li2,4, Ting Tian1,2, Xiao-Mei Li1,2, Xiao-Ming Gao5,6,7, Yi-Ning Yang8,9.   

Abstract

Macrophage migration inhibitory factor (MIF) is an essential mediator of atherosclerotic plaque progression and instability leading to intracoronary thrombosis, therefore contributing to coronary artery disease (CAD). In this study, we investigated the relationship between MIF gene polymorphism and CAD in Chinese Han population. Three single nucleotide polymorphisms (SNP, rs755622, rs1007888 and rs2096525) of MIF gene were genotyped by TaqMan genotyping assay in 1120 control participants and 1176 CAD patients. Coronary angiography was performed in all CAD patients and Gensini score was used to assess the severity of coronary artery lesions. The plasma levels of MIF and other inflammatory mediators were measured by ELISA. The CAD patients had a higher frequency of CC genotype and C allele of rs755622 compared with that in control subjects (CC genotype: 6.5% vs. 3.9%, P = 0.008, C allele: 24.0% vs. 20.6%, P = 0.005). The rs755622 CC genotype was associated with an increased risk of CAD (OR: 1.804, 95%CI: 1.221-2.664, P = 0.003). CAD patients with a variation of rs755622 CC genotype had significantly higher Gensini score compared with patients with GG or CG genotype (all P < 0.05). In addition, the circulating MIF level was highest in CAD patients carrying rs755622 CC genotype (40.7 ± 4.2 ng/mL) and then followed by GC (37.9 ± 3.4 ng/mL) or GG genotype (36.9 ± 3.7 ng/mL, all P < 0.01). Our study showed an essential relationship between the MIF gene rs755622 variation and CAD in Chinese Han population. Individuals who carrying MIF gene rs755622 CC genotype were more susceptible to CAD and had more severe coronary artery lesion. This variation also had a potential influence in circulating MIF levels.

Entities:  

Year:  2021        PMID: 33850223     DOI: 10.1038/s41598-021-87580-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

Review 1.  Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.

Authors:  Daniel Medeiros Moreira; Roberto Leo da Silva; Jefferson Luís Vieira; Tammuz Fattah; Maria Emilia Lueneberg; Carlos Antonio Mascia Gottschall
Journal:  Am J Cardiovasc Drugs       Date:  2015-02       Impact factor: 3.571

Review 2.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 3.  Endothelial function and inflammation in coronary artery disease.

Authors:  D Tousoulis; M Charakida; C Stefanadis
Journal:  Postgrad Med J       Date:  2008-07       Impact factor: 2.401

Review 4.  Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy.

Authors:  Joshua Hartman; William H Frishman
Journal:  Cardiol Rev       Date:  2014 May-Jun       Impact factor: 2.644

5.  Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery disease.

Authors:  Martijn Kwaijtaal; André J van der Ven; Rob van Diest; Cathrien A Bruggeman; Frits W H M Bär; Thierry Calandra; Ad Appels; Fred C G J Sweep
Journal:  Psychosom Med       Date:  2007-01       Impact factor: 4.312

6.  Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke.

Authors:  Joshua C Bis; Susan R Heckbert; Nicholas L Smith; Alexander P Reiner; Kenneth Rice; Thomas Lumley; Lucia A Hindorff; Kristin D Marciante; Daniel A Enquobahrie; Stephanie A Monks; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2007-11-05       Impact factor: 5.162

7.  Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Authors:  Christian Herder; Thomas Illig; Jens Baumert; Martina Müller; Norman Klopp; Natalie Khuseyinova; Christa Meisinger; Stephan Martin; Barbara Thorand; Wolfgang Koenig
Journal:  Atherosclerosis       Date:  2008-02-01       Impact factor: 5.162

Review 8.  Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets.

Authors:  Umar Sadat; Farouc A Jaffer; Marc A M J van Zandvoort; Stephen J Nicholls; Domenico Ribatti; Jonathan H Gillard
Journal:  Circulation       Date:  2014-08-26       Impact factor: 29.690

Review 9.  Inflammation in atherosclerosis: a cause or a result of vascular disorders?

Authors:  Ileana Manduteanu; Maya Simionescu
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

10.  Functional genetic variants within the SIRT2 gene promoter in acute myocardial infarction.

Authors:  Wentao Yang; Feng Gao; Pei Zhang; Shuchao Pang; Yinghua Cui; Lixin Liu; Guanghe Wei; Bo Yan
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

View more
  1 in total

1.  Macrophage migration inhibitory factor gene rs755622 G/C polymorphism and coronary artery disease: A meta-analysis of 8,488 participants.

Authors:  Yan-Yan Li; Hui Wang; Yang-Yang Zhang
Journal:  Front Cardiovasc Med       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.